SCHEMBL23323086

SCHEMBL23323086

CN1CCC(Oc2ccccc2C2CCCN2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ KDM4E B2RXH2 3/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ NPY1R P25929 1/20 0.43
▸ NPY2R P49146 1/20 0.43
▸ MAPT P10636 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ HRH1 P35367 2/20 0.41
▸ HRH3 Q9Y5N1 2/20 0.40
▸ TAAR1 Q96RJ0 1/20 0.39
▸ CHRM1 P11229 2/20 0.38
▸ CHRM2 P08172 1/20 0.38
▸ HTR1A P08908 1/20 0.38
▸ ADRA2A P08913 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ DRD1 P21728 1/20 0.38
▸ SLC6A2 P23975 1/20 0.38
▸ ADRA1A P35348 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23487072 0.93 MEN1 (0.43) MEN1KMT2AKDM4ESMN1; SMN2NPY1R
SCHEMBL28907795 0.87 MEN1 (0.48) MEN1KMT2AHRH1CHRM1CHRM2
SCHEMBL28527428 0.79 TAAR1 (0.43) MEN1KMT2AKDM4ETAAR1CHRM1
SCHEMBL28527431 0.79 TAAR1 (0.43) MEN1KMT2AKDM4ETAAR1CHRM1
SCHEMBL28537464 0.79 TAAR1 (0.43) MEN1KMT2AKDM4ETAAR1CHRM1
SCHEMBL469013 0.76 MEN1 (0.65) MEN1KMT2AKCNH2
SCHEMBL29589447 0.76 MEN1 (0.65) MEN1KMT2AKCNH2
SCHEMBL23323077 0.76 MEN1 (0.65) MEN1KMT2AKCNH2
SCHEMBL23487422 0.73 KDM4E (0.49) MEN1KMT2AKDM4ETAAR1CHRM1
SCHEMBL28535049 0.73 ADRA2C (0.45) MEN1KMT2AKDM4EMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117683029-A Bcl-2 inhibitors 百济神州有限公司 2024-03-12 — — CN disclosed
CN-117430601-A Bcl-2 inhibitors 百济神州有限公司 2024-01-23 — — CN disclosed
CN-112437772-B Bcl-2 inhibitors 百济神州有限公司 2023-11-21 — — CN disclosed
WO-2021110102-A1 METHODS OF CANCER TREATMENT USING BCL-2 INHIBITOR BEIGENE, LTD. (KY) 2021-06-10 — — WO disclosed
WO-2021083135-A1 Bcl-2 INHIBITORS BEIGENE, LTD. (KY) 2021-05-06 — — WO disclosed
CN-112437772-A Bcl-2 inhibitors 百济神州有限公司 2021-03-02 — — CN disclosed
Send feedback